Search Results - "Koch, J E"

Refine Results
  1. 1

    Prospective analysis of health-related quality of life after surgery for spinal metastases by Quraishi, N. A., Pasku, D., Koch, J. E. J., Arealis, G., Boszczyk, B. M., Edwards, K. L.

    Published in European spine journal (01-12-2020)
    “…Purpose Most spinal metastases are detected late, and thus, the impact of treatment on the health-related quality of life (HRQOL) is an important…”
    Get full text
    Journal Article
  2. 2

    Accuracy measures of 1.5-tesla MRI for the diagnosis of ACL, meniscus and articular knee cartilage damage and characteristics of false negative lesions: a level III prognostic study by Koch, Jonathan E J, Ben-Elyahu, Ron, Khateeb, Basel, Ringart, Michael, Nyska, Meir, Ohana, Nissim, Mann, Gideon, Hetsroni, Iftach

    Published in BMC musculoskeletal disorders (29-01-2021)
    “…MRI is the most accurate imaging modality for diagnosing knee pathologies. However, there is uncertainty concerning factors predicting false negative MRI, such…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Factors Associated With Improved Function and Maintenance of Sports Activities at 5 to 10 Years After Autologous Hamstring ACL Reconstruction in Young Men by Hetsroni, Iftach, van-Stee, Mischa, Marom, Niv, Koch, Jonathan E. J., Dolev, Eran, Maoz, Guy, Nyska, Meir, Mann, Gideon

    Published in Orthopaedic journal of sports medicine (01-04-2017)
    “…Background: There are limited data regarding associated factors of return to sports activities at more than 5 years after anterior cruciate ligament (ACL)…”
    Get full text
    Journal Article
  5. 5

    Delta(9)-THC stimulates food intake in Lewis rats: effects on chow, high-fat and sweet high-fat diets by Koch, J E

    Published in Pharmacology, biochemistry and behavior (01-03-2001)
    “…Free-feeding adult male Lewis rats were administered intraperitoneal (i.p.) Delta(9)-tetrahydrocannabinol (THC) in doses of 0.5, 1.0 and 2.5 mg/kg, and effects…”
    Get full text
    Journal Article
  6. 6

    Oligonucleotide-priming methods for the chromosome-specific labelling of alpha satellite DNA in situ by KOCH, J. E, KØLVRAA, S, PETERSEN, K. B, GREGERSEN, N, BOLUND, L

    Published in Chromosoma (01-10-1989)
    “…It is demonstrated that either general staining of the centromeric regions of all primate chromosomes, or selective staining of the centromeric region of…”
    Get full text
    Journal Article
  7. 7

    Alterations in deprivation, glucoprivic and sucrose intake following general, mu and kappa opioid antagonists in the hypothalamic paraventricular nucleus of rats by Koch, J.E., Glass, M.J., Cooper, M.L., Bodnar, R.J.

    Published in Neuroscience (01-06-1995)
    “…While opioid agonists administered into the hypothalamic paraventricular nucleus increase food intake in rats, naloxone reduces deprivation-induced intake…”
    Get full text
    Journal Article
  8. 8

    Maintaining a strong rural dental workforce by Reinhardt, John W., Moncrief, Kathryn Q., Koch, Jade E. J., Samson, Kaeli K., Yu, Fang

    Published in Journal of dental education (01-01-2023)
    “…Aims This study was designed to examine demographics of University of Nebraska Medical Center College of Dentistry graduates over a recent 10‐year period and…”
    Get full text
    Journal Article
  9. 9

    Schmorl Node-A Cause of Acute Thoracic Pain: A Case Report and Pathophysiological Mechanism by Hershkovich, Oded, Koch, Jonathan E J, Grevitt, Michael P

    Published in International journal of spine surgery (01-06-2020)
    “…We report a case of a patient with an acute symptomatic Schmorl node (SN) that spontaneously resolved with characteristic imaging findings. The extensive…”
    Get full text
    Journal Article
  10. 10

    Central opioid receptor subtype antagonists differentially reduce intake of saccharin and maltose dextrin solutions in rats by Beczkowska, I W, Koch, J E, Bostock, M E, Leibowitz, S F, Bodnar, R J

    Published in Brain research (06-08-1993)
    “…Opioid modulation of ingestion includes general opioid antagonism of deprivation-induced water intake and intake of sucrose and saccharin solutions. Previous…”
    Get more information
    Journal Article
  11. 11

    Modulation of morphine antinociception by the brain-penetrating H2 antagonist zolantidine : detailed characterization in five nociceptive test systems by NALWALK, J. W, KOCH, J. E, BARKE, K. E, BODNAR, R. J, HOUGH, L. B

    Published in Pharmacology, biochemistry and behavior (01-03-1995)
    “…Because histamine (HA) in the CNS may be a mediator of antinociception, a detailed investigation of the effects of the brain-penetrating H2 antagonist…”
    Get full text
    Journal Article
  12. 12

    Differential modulation of angiotensin II and hypertonic saline-induced drinking by opioid receptor subtype antagonists in rats by Ruegg, H, Hahn, Barry, Koch, J E, Bodnar, R J

    Published in Brain research (28-01-1994)
    “…Opioid modulation of ingestion includes general opioid antagonism of different forms of water intake, mu 2 receptor modulation of deprivation-induced water…”
    Get more information
    Journal Article
  13. 13

    Involvement of mu1 and mu2 opioid receptor subtypes in tail-pinch feeding in rats by Koch, J E, Bodnar, R J

    Published in Physiology & behavior (01-03-1993)
    “…Tail-pinch feeding (TPF) in rats is decreased following general (naltrexone, NTX) and mu (Cys2-Tyr3-Orn5-Pen7-amide, CTOP) opioid antagonists, but not…”
    Get more information
    Journal Article
  14. 14

    Thrombophilia-Associated Factors in Patients with Spontaneous Osteonecrosis of the Knee by Marom, Niv, Koch, Jonathan EJ, Beer, Yiftah, Ellis, Martin, Ganot, Gil, Nyska, Meir, Maoz, Guy, Hetsroni, Iftach

    Published in Cartilage (01-01-2019)
    “…Objective To test whether patients with spontaneous osteonecrosis of the knee (SONK) are characterized by abnormal levels of thrombophilia-associated factors…”
    Get full text
    Journal Article
  15. 15

    Analysis of central opioid receptor subtype antagonism of hypotonic and hypertonic saline intake in water-deprived rats by Bodnar, Richard J., Glass, Michael J., Koch, James E.

    Published in Brain research bulletin (1995)
    “…Intake of either hypotonic or hypertonic saline solutions is modulated in part by the endogenous opioid system. Morphine and selective mu and delta opioid…”
    Get full text
    Journal Article
  16. 16

    Extensive Arthroscopic Chondroplasty for Cartilage Hyperplasia of the Femoral Condyle Causing Recurrent Knee Locking in a Patient With Multiple Epiphyseal Dysplasia by Koch, Jonathan E.J., M.D, Mann, Gideon, M.D, Hetsroni, Iftach, M.D

    Published in Arthroscopy techniques (Amsterdam) (01-04-2016)
    “…Abstract Multiple epiphyseal dysplasia is a genetically heterogeneous group of diseases causing altered enchondral ossification. It may affect the knee, among…”
    Get full text
    Journal Article
  17. 17

    Treatment of angina pectoris with isosorbide-5-mononitrate. A multicenter study in general practice by Beck, E J, Koch, J E

    Published in Cardiology (1991)
    “…In this multicenter study 191 practitioners treated 532 patients with coronary artery disease and chronic stable angina pectoris by isosorbide-5-mononitrate…”
    Get more information
    Journal Article
  18. 18

    Naltrexone, serotonin receptor subtype antagonists, and glucoprivic intake: 1. 2-Deoxy-D-glucose by Beczkowska, I W, Koch, J E, Bodnar, R J

    Published in Pharmacology, biochemistry and behavior (01-08-1992)
    “…Inhibition of deprivation-induced intake by naloxone was significantly enhanced by the 5-hydroxytryptamine3 (5-HT3) antagonist ICS-205,930. Interactions…”
    Get more information
    Journal Article
  19. 19

    Naltrexone, serotonin receptor subtype antagonists, and glucoprivic intake: 2. Insulin by Koch, J E, Beczkowska, I W, Bodnar, R J

    Published in Pharmacology, biochemistry and behavior (01-08-1992)
    “…Opiate antagonist inhibition of deprivation-induced intake and 2-deoxy-D-glucose (2DG) hyperphagia is significantly enhanced by the 5-hydroxytryptamine3…”
    Get more information
    Journal Article
  20. 20

    Potentiation of 2-deoxy-D-glucose antinociception, but not hyperphagia by zolantidine, a histamine (H2) receptor antagonist by Koch, J E, Hough, L B, Bodnar, R J

    Published in Pharmacology, biochemistry and behavior (01-02-1992)
    “…Antagonism of the histamine (H2) receptor reduces antinociception induced by naloxone-resistant foot-shock, naloxone-sensitive foot-shock, and morphine with a…”
    Get more information
    Journal Article